---
title: "Jetsen: Net profit for the first three quarters was 212 million yuan, a year-on-year decrease of 41.35%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262768903.md"
description: "On October 26th, Jetsen released its Q3 report for 2025, with third-quarter operating revenue of 685 million yuan, a year-on-year increase of 3.48%; net profit of 66.9355 million yuan, a year-on-year decrease of 40.27%. For the first three quarters of 2025, operating revenue was 2.052 billion yuan, a year-on-year decrease of 2.89%; net profit was 212 million yuan, a year-on-year decrease of 41.35%"
datetime: "2025-10-26T09:49:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262768903.md)
  - [en](https://longbridge.com/en/news/262768903.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262768903.md)
---

# Jetsen: Net profit for the first three quarters was 212 million yuan, a year-on-year decrease of 41.35%

On October 26th, Jetsen released its Q3 2025 report, showing a third-quarter revenue of 685 million yuan, a year-on-year increase of 3.48%; net profit was 66.9355 million yuan, a year-on-year decrease of 40.27%. For the first three quarters of 2025, revenue was 2.052 billion yuan, a year-on-year decrease of 2.89%; net profit was 212 million yuan, a year-on-year decrease of 41.35%

### Related Stocks

- [300182.CN](https://longbridge.com/en/quote/300182.CN.md)

## Related News & Research

- [KAP shifts engineered products output to Czech Republic, India; to close Hessisch Lichtenau plant](https://longbridge.com/en/news/286927478.md)
- [All three branches of government should have a stock trading ban: House Republican](https://longbridge.com/en/news/286682343.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)
- [BOROUX Reports Surge in Demand as EPA Confirms Microplastics in Drinking Water](https://longbridge.com/en/news/286918563.md)
- [UAE among first globally to approve new obesity, hypertension treatments](https://longbridge.com/en/news/286707352.md)